{'text': 'Genzyme’s Olipudase Alfa Gains Breakthrough Designation', 'publisher': {'href': 'https://www.contractpharma.com', 'title': 'Contract Pharma'}, 'created_at': 'Mon, 06 Apr 2015 07:00:00 GMT', 'description': 'Genzyme’s Olipudase Alfa Gains Breakthrough Designation  Contract Pharma', 'url': 'https://news.google.com/rss/articles/CBMiwwFBVV95cUxNbGlLXzNpVzBjdS1wczNOV25PODV2amJYOG5ucjliaWpJRXZ3ZXpxNGhCUG8yRVhCUndZZjZwUWFUczYyYjJBSEhUQ1REa1BSUHg2S2hncktBXzV3dGxxY21ObDNGOG1QTEpvOVdENkhuUWxjQXJzWkdWLVRZdmJYLXpJZUphaV8wOEVGZmxxV2xUdlA0UXVKd1BEWkFPcVpUWXQ2T1Z0eDcycHBKU2tDOWVOZTRTUTBtRm94Wk1PYVZmLUU?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Monday interview: Christophe Weber, Takeda CEO', 'publisher': {'href': 'https://www.ft.com', 'title': 'Financial Times'}, 'created_at': 'Sun, 05 Apr 2015 07:00:00 GMT', 'description': 'Monday interview: Christophe Weber, Takeda CEO  Financial Times', 'url': 'https://news.google.com/rss/articles/CBMicEFVX3lxTE5KanpQeFNQT1NEeXhTNnl3Y2ZSeHpSNWU4MnktaWlkZS1OQzdrU0tRemEwdkR3aVllcHp6UHpLMGRZT3JQT09zeGwwWkJPbHZwNE5Mb2JwSFd6N2VVc2liTUpVb1JuSVNnQXZHdmxaTFI?oc=5&hl=en-US&gl=US&ceid=US:en'}
